EUL

'Corbevax under WHO's detailed review for emergency use listing'

The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The company has also submitted applications for Corbevax registrations in several countries from Asia, Africa Central and South America.

More in EUL

Process on track to get WHO nod for Covaxin, says Bharat Biotech

An emergency approval from the WHO will allow Bharat Biotech to export Covaxin to more countries and enable easy international travel for people who have received this vaccine. Soumya Swaminathan, WHO's chief scientist, told ET on Tuesday that the "process is ongoing".
Submitted all documents for Covaxin EUL to WHO: Ella

Bharat Biotech has submitted all the documents required for emergency use listing (EUL) of indigenously developed Covid-19 vaccine Covaxin to the World Health Organisation (WHO), its chairman and managing director Dr Krishna Ella said on Monday.
WHO accepts expression of interest for Covaxin emergency use listing

Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of interest (EoI) for the inactivated vaccine after it provided additional data sought by WHO.
WHO validates Sinovac Covid-19 vaccine

WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement. It also allows countries to expedite their own regulatory approval to import and administer Covid-19 vaccines.